HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Rose Sheet

Executive Summary

P&G Beauty: Despite overall market slowdown, company continues to see strength in its premium beauty offerings, including Olay Pro-X, Secret Clinical Strength, Nice 'N Easy Perfect 10 and Gucci fine fragrance, Procter & Gamble says April 30. In third quarter Nice 'N Easy value share was up nearly two points behind Perfect 10, which is "offsetting declines in minor hair color brands," firm says. Skin-care organic volume declined mid-single digits following price increases in the North American and Central Eastern Europe, Middle East and Africa regions; however, value share of the facial skin-care market was up nearly a point, driven by expansion of Olay in developing markets. Prestige fragrance volume declined double digits, firm notes. Net beauty sales declined 9% in the quarter to $4.3 billion, with organic sales in line with the previous year. The sales performance contributed to a decline in net beauty earnings, which fell 14% to $504 million. Overall, P&G revenue declined 8% to $18.4 billion for the third quarter; net earnings fell 4% to $2.61 billion

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel